Results 61 to 70 of about 10,171 (92)

GDF15 and its receptors as pathways mediating smoking related weight change. [PDF]

EBioMedicine
Tinworth AC, Iona A, Yao P, Millwood IY, Fry H, Clarke J, Wang B, Mazidi M, Kartsonaki C, Walters RG, Du H, Yu C, Chen Y, Sun D, Yang L, Schmidt DV, Lv J, Avery D, Li L, Bennett DA, Peto R, Clarke R, Bragg F, Chen Z, China Kadoorie Biobank Collaborative Group.   +24 more
europepmc   +1 more source

Comprehensive transcriptomic characterization of two melanoma cell lines with acquired dual resistance to BRAF and MEK inhibitors. [PDF]

Sci Rep
Kujawa T, Simiczyjew A, Kot M, Gambin T, Nowak D, Kobiela T.   +5 more
europepmc   +1 more source

Advances in Tissue-Agnostic Targeting in Cancer Therapeutics: Current Approvals, Challenges, and Future Directions. [PDF]

Oncol Res
Rubinstein M, Hong ML, Nanda RK, Jones DT, Aboaid H, Myat YM, Thein KZ.   +6 more
europepmc   +1 more source

<i>RET</i> Gene Alterations in Clinical Practice: A Comprehensive Review and Database Update. [PDF]

Genes (Basel)
Ricciardi Tenore C, Tulli E, Perrucci A, Bertozzi R, Fortuna L, Maneri G, Santonocito C, Urbani A, De Bonis M, Minucci A.   +9 more
europepmc   +1 more source

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer. [PDF]

J Clin Oncol
Besse B, Subbiah V, Curigliano G, Bowles DW, Doebele RC, Mansfield AS, Baik CS, de Lima Lopes G, Paz-Ares L, Taylor MH, Tan DSW, Alonso G, Gadgeel SM, Kalemkerian GP, Ou SI, van der Wekken AJ, Becerra CR, Evangelist M, Griesinger F, Liu SV, Lou Y, Mazières J, Melear JM, Narang M, Saxena A, Thomas M, Wang S, Thomassen A, Lee DH, Kim DW, Gainor JF.   +30 more
europepmc   +1 more source

Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives. [PDF]

Int J Mol Sci
Astore M, Fabbri L, Monte A, Deiana C, Rizzo A, Tavolari S, Deserti M, Brandi G, Palloni A, Frega G.   +9 more
europepmc   +1 more source

Precision Medicine in Treating Lung Cancer: A Narrative Review on Treatments Targeting Oncogenic Genetic Mutations. [PDF]

Cureus
Chitneni E, Venugopal A, Okorie CO, George AT, Arya A, Arias D, Yasin O, Cereser Prado de Souza L, Afshan R, Dave VA.   +9 more
europepmc   +1 more source

Advances in Targeted Therapy for Non-Small-Cell Lung Cancer: Current Progress and Future Directions. [PDF]

Int J Mol Sci
Peshin S, Takrori E, Yazji JH, Haque J, Dharia A, Mithani MS, Anum F, Asfeen U, Couch JK, Donovan M, Singal S.   +10 more
europepmc   +1 more source

Successful treatment with sintilimab plus anlotinib for SMARCA4-deficient non-small cell lung cancer withMET exon 14 skipping: a case report. [PDF]

Nagoya J Med Sci
Zhao H, Zhang C, Chen D, Ye W, Shi Q.
europepmc   +1 more source

Gene fusions in melanocytic lesions: an updated comprehensive review. [PDF]

J Pathol Transl Med
Lenskaya V, Erikson L, Prieto VG, Cho WC.   +3 more
europepmc   +1 more source